Uchiyama A - Search Results

1

Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model.

Kuga H, Morisaki T, Nakamura K, Onishi H, Noshiro H, Uchiyama A, Tanaka M, Katano M. Kuga H, et al. Among authors: uchiyama a. Oncogene. 2003 Oct 30;22(49):7838-47. doi: 10.1038/sj.onc.1207046. Oncogene. 2003. PMID: 14586410

2

Inhibition of interferon-gamma-activated nuclear factor-kappa B by cyclosporin A: A possible mechanism for synergistic induction of apoptosis by interferon-gamma and cyclosporin A in gastric carcinoma cells.

Beppu K, Morisaki T, Matsunaga H, Uchiyama A, Ihara E, Hirano K, Kanaide H, Tanaka M, Katano M. Beppu K, et al. Among authors: uchiyama a. Biochem Biophys Res Commun. 2003 Jun 13;305(4):797-805. doi: 10.1016/s0006-291x(03)00853-2. Biochem Biophys Res Commun. 2003. PMID: 12767900

3

Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation.

Kojima M, Morisaki T, Izuhara K, Uchiyama A, Matsunari Y, Katano M, Tanaka M. Kojima M, et al. Among authors: uchiyama a. Oncogene. 2000 Feb 24;19(9):1225-31. doi: 10.1038/sj.onc.1203427. Oncogene. 2000. PMID: 10713711

4

Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.

Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, Katano M. Sasaki N, et al. Among authors: uchiyama a. Clin Cancer Res. 2001 Dec;7(12):4136-42. Clin Cancer Res. 2001. PMID: 11751513

5

A large quantity of CD3-/CD19-/CD16- lymphocytes in malignant pleural effusion from a patient with recurrent cholangio cell carcinoma.

Onishi H, Morisaki T, Kuga H, Katano M, Doi F, Uchiyama A, Sugitani A, Wada J, Chijiiwa K, Tanaka M. Onishi H, et al. Among authors: uchiyama a. Immunol Invest. 2002 May;31(2):121-35. doi: 10.1081/imm-120004803. Immunol Invest. 2002. PMID: 12148948

6

Candidate host marker for peritoneal dissemination.

Hashizume K, Uchiyama A, Sasaki N, Noshiro H, Morisaki T, Tanaka M, Katano M. Hashizume K, et al. Among authors: uchiyama a. Anticancer Res. 2002 May-Jun;22(3):1781-6. Anticancer Res. 2002. PMID: 12168869

7

TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.

Odate S, Nakamura K, Onishi H, Kojima M, Uchiyama A, Nakano K, Kato M, Tanaka M, Katano M. Odate S, et al. Among authors: uchiyama a. Lung Cancer. 2013 Mar;79(3):205-14. doi: 10.1016/j.lungcan.2012.12.004. Epub 2013 Jan 9. Lung Cancer. 2013. PMID: 23312550

8

Odate S, Onishi H, Nakamura K, Kojima M, Uchiyama A, Kato M, Katano M. Odate S, et al. Among authors: uchiyama a. Anticancer Res. 2013 Sep;33(9):3699-703. Anticancer Res. 2013. PMID: 24023298

9

A possible role of TGF-beta in the formation of malignant effusions.

Ikubo A, Morisaki T, Katano M, Kitsuki H, Anan K, Uchiyama A, Tanaka M, Torisu M. Ikubo A, et al. Among authors: uchiyama a. Clin Immunol Immunopathol. 1995 Oct;77(1):27-32. doi: 10.1016/0090-1229(95)90133-7. Clin Immunol Immunopathol. 1995. PMID: 7554479

10

Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential.

Anan K, Morisaki T, Katano M, Ikubo A, Tsukahara Y, Kojima M, Uchiyama A, Kuroki S, Torisu M, Tanaka M. Anan K, et al. Among authors: uchiyama a. Eur J Surg Oncol. 1998 Feb;24(1):28-33. doi: 10.1016/s0748-7983(98)80121-2. Eur J Surg Oncol. 1998. PMID: 9542512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

575 results

Search Page

Filters